Jacobi Capital Management’s Navidea Biopharmaceuticals Inc. NAVB Stock Holding History

Jacobi Capital Management’s Portfolio NAVB Stock Details NAVB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-1,000	Closed	-$2K	–	1455
2021 Q3	$2K	Hold	1,000	–	–	﹤0.01%	1357
2021 Q2	$2K	Hold	1,000	–	–	﹤0.01%	1299
2021 Q1	$2K	Hold	1,000	–	–	﹤0.01%	1276
2020 Q4	$2K	Hold	1,000	–	–	﹤0.01%	1196
2020 Q3	$3K	Hold	1,000	–	–	﹤0.01%	1065
2020 Q2	$4K	Hold	1,000	–	–	﹤0.01%	973
2020 Q1	$1K	Hold	1,000	–	–	﹤0.01%	1122
2019 Q4	$1K	Hold	1,000	–	–	﹤0.01%	1058
2019 Q3	$1K	Hold	1,000	–	–	﹤0.01%	1039
2019 Q2	$1K	Hold	1,000	–	–	﹤0.01%	1030
2019 Q1	$3K	Hold	1,000	–	–	﹤0.01%	873
2018 Q4	$2K	Hold	1,000	–	–	﹤0.01%	884
2018 Q3	$5K	Sell	1,000 -7	-0.7%	-$27	﹤0.01%	805
2018 Q2	$5K	Hold	1,007	–	–	﹤0.01%	841
2018 Q1	$7K	Hold	1,007	–	–	﹤0.01%	762
2017 Q4	$8K	Hold	1,007	–	–	﹤0.01%	714
2017 Q3	$9K	Hold	1,007	–	–	﹤0.01%	662
2017 Q2	$10K	Buy	1,007 +7	+0.7%	+$69	﹤0.01%	581
2017 Q1	$10K	Buy	1,000 +500	+100%	+$5.68K	0.01%	471
2016 Q4	$6K	Sell	500 -500	-50%	-$7.93K	﹤0.01%	489
2016 Q3	$17K	Hold	1,000	–	–	0.01%	394
2016 Q2	$10K	Buy	+1,000	New	+$19.6K	0.01%	463

Other funds holding NAVB

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

ACM

Allred Capital Management Dallas, Texas $275M AUM 18.19% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Jacobi Capital Management's NAVB Position: Q4 2021 in Review

Jacobi Capital Management sold out of Navidea Biopharmaceuticals Inc. (NAVB) in Q4 2021, closing a stake of 1,000 shares — an estimated $2K sold.

Jacobi Capital Management first reported a position in NAVB in Q2 2016 and held it in 22 quarters. The position peaked at $17K in Q3 2016. 31 funds tracked by Wall St. Rank hold NAVB as of Q4 2021.

Jacobi Capital Management reported no remaining Navidea Biopharmaceuticals Inc. position as of Q4 2021 after selling out during the quarter.
Jacobi Capital Management sold 1,000 Navidea Biopharmaceuticals Inc. shares in Q4 2021, an estimated $2K.
Jacobi Capital Management first reported a position in Navidea Biopharmaceuticals Inc. in Q2 2016 and held it in 22 quarters.
Jacobi Capital Management's Navidea Biopharmaceuticals Inc. position peaked at $17K in Q3 2016.
31 funds tracked by Wall St. Rank held Navidea Biopharmaceuticals Inc. as of Q4 2021.

Based on Jacobi Capital Management's 13F filing for Q4 2021, filed 14 Feb 2022.